about us

about us

Borna Biopharma Company

  • Company history

Borna Pharmaceutical Company, established in 2014, has been active in the production of biotechnology pharmaceutical products since 2011. The company has produced the raw material EGF and marketed Bornamin cream by setting up a well-equipped site at the Pharmaceutical Technology Units Growth Center of the University of Tehran. Also, the injectable drugs Bornaprot and Bornaplate are on the way to obtaining a production license, and the company's Bornaheal cream is also undergoing final approval.

  • Existential philosophy

Borna Pharmaceutical Company was founded on the basis of research and development in the field of biotechnological drugs to help improve the health of society and increase the quality of life of patients by providing new and high-quality pharmaceutical products based on local knowledge. This company seeks to meet domestic needs and develop exports by focusing on innovation, utilizing human resources expertise and using advanced technologies.

  • mission

In its future horizon, Borna Pharmaceutical Company aims to become one of the leading biotechnology companies in the region. By expanding diverse and sustainable pharmaceutical products, this company is trying to gain a distinctive position in the domestic and international markets as a symbol of quality, innovation and trust.

 
  • International markets

Our company, with the aim of expanding its activities in the international arena, has a special focus on producing pharmaceutical products in accordance with global standards. The company seeks to gain a place in global markets through the localization of advanced technologies and the production of high-quality biotechnological drugs. It also tries to contribute to the promotion of international health by planning to export products such as Bernamin cream and specialized injectable drugs. Attending exhibitions and cooperating with global scientific centers is also part of the strategy to enter these markets.

  • Global standards

Borna Pharmaceutical Company produces and supplies innovative and effective pharmaceutical products in the human field by utilizing the best raw materials and complying with international standards such as GXP, PICS, and WHO, as well as the rules of the Food and Drug Administration. By establishing quality control processes based on USP, BP, and EP standards, the company always focuses on producing drugs with optimal clinical efficacy and improving the health of the community. The main goal of this complex is to develop high-quality biotechnology products and have a strong presence in domestic and international markets.

  • Company structure

Borna Pharmaceutical Company combines cutting-edge biotechnology knowledge, experience in the pharmaceutical industry, and a commitment to professional ethics to achieve the company's lofty goals of improving community health and producing high-quality products. This worthy synergy has made Borna a symbol of innovation and commitment in the pharmaceutical industry.

 
 

About Borna Pharmaceutical Company

Borna Pharmaceutical Company has been playing a role in meeting domestic needs and developing exports by producing new biological and biosimilar drugs since 2014. This company is taking steps towards improving health by localizing production knowledge and relying on expertise.

USEFUL LINKS

CONTACT US

  • No. 1462, Pharmaceutical Technology Incubator, End of North Kargar Street, Tehran, Iran
  • postal code: 1439955991
  • tell: 021-40883240
  • mail: info@bornabiopharma.com
© 2025 BORNA BIOPHARMA COMPANY. All rights reserved. | Designed and developed with care by DUORUN